Stoke Therapeutics Inc
STOK
NASDAQ
Biotechnology
$31.27
USD
-0.04 (-0.13%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $2.04B
Volume 495.1K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
VRDN | Viridian Therapeutics Inc | $2.50B | - | +23220.3% | - | |
ADMA | ADMA Biologics Inc | $2.22B | 13.12 | +8.0% | - | |
SLS | Sellas Life Sciences Group Inc | $2.12B | - | - | - | |
STOK | Stoke Therapeutics Inc | $2.07B | - | -86.2% | - | |
TSHA | Taysha Gene Therapies Inc | $2.04B | - | +3.4% | - | |
ZBIO | Zenas Biopharma Inc | $2.00B | - | - | - | |
AGIO | Agios Pharmaceuticals Inc | $1.93B | - | +140.6% | - | |
BCAX | Bicara Therapeutics Inc | $1.82B | - | - | - | |
DMRA | Damora Therapeutics Inc | $1.82B | - | - | - |
Top Peer by Growth
Viridian Therapeutics Inc
+23220.3% YoY Revenue
Lowest P/E Ratio
ADMA Biologics Inc
12.97x P/E
Best 1-Year Return
Precigen Inc
+239.8% Return